Purchases and Sales Made in Q4 2021 in Edgewise Therapeutics, Inc. (EWTX)
This table provides information about the institutional ownership of Edgewise Therapeutics, Inc. (EWTX) during Q4 2021. The information is specifically focused on institutions that hold shares of Edgewise Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 17, 2024
Q4 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-14.9K- 49.8% |
$215K - $334K
|
15K
$463K
|
|
|
Feb 14, 2022
Q4 2021
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-31.3KClosed |
$451K - $701K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
High Vista Strategies LLC
Boston, MA |
SELL
|
- |
-39.1KClosed |
$564K - $877K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-50KClosed |
$721K - $1.12M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-98.4KClosed |
$1.42M - $2.21M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-206K- 11.88% |
$2.96M - $4.61M
|
1.53M
$47M
|
|
|
Feb 14, 2022
Q4 2021
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-553K- 78.99% |
$7.97M - $12.4M
|
147K
$4.53M
|